-
1
-
-
22844441609
-
Frequency of elevated serum aluminum levels in adult dialysis patients
-
DOI 10.1053/j.ajkd.2005.04.020, PII S0272638605005664
-
Jaffe JA, Liftman C, Glickman JD. Frequency of elevated serum aluminium levels in adult dialysis patients. Am J Kidney Dis 2005; 46: 316-319 (Pubitemid 41040361)
-
(2005)
American Journal of Kidney Diseases
, vol.46
, Issue.2
, pp. 316-319
-
-
Jaffe, J.A.1
Liftman, C.2
Glickman, J.D.3
-
2
-
-
0027403453
-
Diagnostic and therapeutic approaches to aluminium overload in dialysed patients - Representative study by questionnaire in West German dialysis units in 1989-1990
-
Humpfner A, Hummel S, Schultz W. Diagnosis and therapeutic approaches to aluminium overload in dialysed patients-representative study questionnaire in West German Dialysis units in 1989-1990. Nephrol Dial Transplant 1993; 8: S51-S54 (Pubitemid 23115854)
-
(1993)
Nephrology Dialysis Transplantation
, vol.8
, Issue.SUPPL. 1
, pp. 51-54
-
-
Humpfner, A.1
Hummel, S.2
Schulz, W.3
-
3
-
-
33751564527
-
A new era in phosphate binder therapy: What are the options?
-
Salusky IB. A new era in phosphate binder therapy: what are the options? Kidney Int 2006; 105: S10-S15
-
(2006)
Kidney Int
, vol.105
-
-
Salusky, I.B.1
-
4
-
-
0141432172
-
NKF-K/DOQI. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease
-
NKF-K/DOQI. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S108-S122
-
(2003)
Am J Kidney Dis
, vol.42
-
-
-
5
-
-
77951683663
-
Henrich WLAluminium toxicity in end-stage renal disease
-
BD Rose (ed) Waltham, MA: UpToDate
-
Cronin RE, Henrich WLAluminium toxicity in end-stage renal disease. In: BD Rose (ed). UpToDate. Waltham, MA: UpToDate, 2006
-
(2006)
UpToDate
-
-
Cronin, R.E.1
-
6
-
-
0024505752
-
Exacerbation of aluminium encephalopathy after treatment with desferrioxamine
-
McCauley J, Sorkin MI. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. Nephrol Dial Transplant 1989; 4: 110-114 (Pubitemid 19077599)
-
(1989)
Nephrology Dialysis Transplantation
, vol.4
, Issue.2
, pp. 110-114
-
-
McCauley, J.1
Sorkin, M.I.2
-
7
-
-
0027160171
-
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection: In vitro and in vivo animal studies
-
Boelaert JR, de Locht M, Van Cutsem J, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993; 91: 1979-1986 (Pubitemid 23141469)
-
(1993)
Journal of Clinical Investigation
, vol.91
, Issue.5
, pp. 1979-1986
-
-
Boelaert, J.R.1
De Locht, M.2
Van Cutsem, J.3
Kerrels, V.4
Cantinieaux, B.5
Verdonck, A.6
Van Landuyt, H.W.7
Schneider, Y.-J.8
-
8
-
-
0026318477
-
Deferoxamine therapy and mucormycosis in dialysis patients: Report of an international registry
-
Boelaert JR, Fenves AZ, Coburn JW. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis 1991; 18: 660-667
-
(1991)
Am J Kidney Dis
, vol.18
, pp. 660-667
-
-
Boelaert, J.R.1
Fenves, A.Z.2
Coburn, J.W.3
-
9
-
-
0024587762
-
Irreversible ocular toxicity from single 'challenge' dose of deferoxamine
-
Bene C, Manzler A, Bene D, et al. Irreversible ocular toxicity from single "challenge" dose of deferoxamine. Clin Nephrol 1989; 31: 45-48 (Pubitemid 19033536)
-
(1989)
Clinical Nephrology
, vol.31
, Issue.1
, pp. 45-48
-
-
Bene, C.1
Manzler, A.2
Bene, D.3
Kranias, G.4
-
10
-
-
0023240050
-
Ocular toxicity after a single intravenous dose of desferrioxamine in 2 hemodialyzed patients
-
Pengloan J, Dantal J, Rossazza C, et al. Ocular toxicity after a single intravenous dose of desferrioxamine in 2 hemodialyzed patients. Nephron 1987; 46: 211-212 (Pubitemid 17074323)
-
(1987)
Nephron
, vol.46
, Issue.2
, pp. 211-212
-
-
Pengloan, J.1
Dantal, J.2
Rossazza, C.3
-
11
-
-
0023877556
-
Acute visual and auditory neuro-toxicity in patients with end-stage renal disease receiving desferrioxamine
-
Cases A, Kelly J, Sabater J, et al. Acute visual and auditory neuro-toxicity in patients with end-stage renal disease receiving desferrioxamine. Clin Nephrol 1988; 29: 176-178
-
(1988)
Clin Nephrol
, vol.29
, pp. 176-178
-
-
Cases, A.1
Kelly, J.2
Sabater, J.3
-
12
-
-
0030045385
-
Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules
-
Barata JD, D'Haese PC, Pires C, et al. Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules. Nephrol Dial Transplant 1996; 11: 125-132 (Pubitemid 26038477)
-
(1996)
Nephrology Dialysis Transplantation
, vol.11
, Issue.1
, pp. 125-132
-
-
Barata, J.D.1
D'Haese, P.C.2
Pires, C.3
Lamberts, L.V.4
Simoes, J.5
De Broe, M.E.6
-
13
-
-
0028849828
-
Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload
-
D'Haese PC, Couttenye MM, Goodman WG, et al. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload. Nephrol Dial Transplant 1995; 10: 1874-1884
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 1874-1884
-
-
D'Haese, P.C.1
Couttenye, M.M.2
Goodman, W.G.3
-
14
-
-
0029907095
-
Efficacy of low-dose desferrioxamine for the estimation of aluminium overload in haemodialysis patients
-
DOI 10.1007/BF00820731
-
Janssen MJ, van Boven WP. Efficacy of low-dose desferrioxamine for the estimation of aluminium overload in haemodialysis patients. Pharm World Sci 1996; 18: 187-191 (Pubitemid 26364528)
-
(1996)
Pharmacy World and Science
, vol.18
, Issue.5
, pp. 187-191
-
-
Janssen, M.J.A.1
Van Boven, W.P.L.2
-
15
-
-
0031801351
-
Ultrafiltrable aluminium after very low doses of desferrioxamine
-
DOI 10.1093/ndt/13.6.1538
-
Canteros A, Diaz-Corte C, Fernandez-Martin JL, et al. Ultrafiltrable aluminium after very low doses of desferrioxamine. Nephrol Dial Transplant 1998; 13: 1538-1542 (Pubitemid 28254334)
-
(1998)
Nephrology Dialysis Transplantation
, vol.13
, Issue.6
, pp. 1538-1542
-
-
Canteros, A.1
Diaz-Corte, C.2
Fernandez-Martin, J.-L.3
Gago, E.4
Fernandez-Merayo, C.5
Cannata, J.6
-
16
-
-
0032745430
-
Use of a desferrioxamine 'microdose' to chelate aluminum in hemodialysis patients
-
Jorge C, Gil C, Possante M, et al. Use of a desferrioxamine "micro-dose" to chelate aluminium in haemodialysis patients. Clin Nephrol 1999; 52: 335-336 (Pubitemid 29524969)
-
(1999)
Clinical Nephrology
, vol.52
, Issue.5
, pp. 335-336
-
-
Jorge, C.1
Gil, C.2
Possante, M.3
Catarino, M.C.4
Cruz, A.5
Andrade, R.6
Teixeira, R.7
Santos, N.8
Ferreira, A.9
-
17
-
-
0022844293
-
Diagnosis of aluminium-related bone disease and treatment of aluminium toxicity with deferoxamine
-
Jack W, Norris KC. Diagnosis of aluminium-related bone disease and treatment of aluminium toxicity with deferoxamine. SeminNephrol 1986; 6: 12-21
-
(1986)
SeminNephrol
, vol.6
, pp. 12-21
-
-
Jack, W.1
Norris, K.C.2
-
18
-
-
1342335772
-
Effect of aluminum on parathyroid hormone secretion
-
Morrissey J, Slatopolsky E. Effect of aluminium on parathyroid hormone secretion. Kidney Int 1986; 18: S41-S44 (Pubitemid 16114644)
-
(1986)
Kidney International
, vol.28
, Issue.SUPPL. 18
-
-
Morrissey, J.1
Slatopolsky, E.2
-
19
-
-
0025228544
-
Hyperparathyroidism after aluminium depletion
-
Almirall J, Campistol JM, Torras A, et al. Hyperparathyroidism after aluminium depletion. Nephron 1990; 55: 94-95
-
(1990)
Nephron
, vol.55
, pp. 94-95
-
-
Almirall, J.1
Campistol, J.M.2
Torras, A.3
-
20
-
-
63849210667
-
Chemistry and history of phosphate binder
-
Koiwa F, Sato Y. Chemistry and history of phosphate binder. Clin Calcium 2009; 19: 198-204
-
(2009)
Clin Calcium
, vol.19
, pp. 198-204
-
-
Koiwa, F.1
Sato, Y.2
-
21
-
-
65349156550
-
Role of medication in the level of aluminium in the blood of chronic renal patients
-
Bohrer D, Bertagnolli DC, de Oliveira SM, et al. Role of medication in the level of aluminium in the blood of chronic renal patients. Nephrol Dial Transplant 2009; 24: 1277-1281
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 1277-1281
-
-
Bohrer, D.1
Bertagnolli, D.C.2
De Oliveira, S.M.3
|